Zenas Biopharma (ZBIO)'s 30-day implied volatility (IV30) was 65.1% at the close on October 30, 2026, down from 69.6% the day before, against a 52-week range of 55.0% to 174.6%. Its 20-day historical volatility was 65.1%.
Data as of October 30, 2026.